v3.26.3
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Selected Financial Information of Reportable Segments
Selected financial information, including significant segment expenses, for our reportable segment is as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net operating revenues$1,609.5 $1,477.5 $4,793.5 $4,390.6 
Less:
Salaries and benefits840.7 784.8 2,479.1 2,314.8 
Other operating expenses244.4 229.2 738.8 660.0 
Occupancy costs15.0 14.9 44.9 44.5 
Supplies65.0 64.6 195.4 189.9 
General and administrative expenses45.6 39.6 138.1 124.6 
Net income attributable to noncontrolling interests55.2 48.1 162.4 135.9 
Other segment items(1)
(3.0)(3.8)(8.6)(11.4)
Adjusted EBITDA$346.6 $300.1 $1,043.4 $932.3 
(1)Includes interest and dividend income, investment gain or loss, and equity in net income of nonconsolidated affiliates.
Schedule of Reconciliation of Segment Adjusted EBITDA to Income from Continuing Operations Before Income Tax Expense
Segment reconciliation (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Adjusted EBITDA$346.6 $300.1 $1,043.4 $932.3 
Stock-based compensation(15.0)(14.3)(40.3)(38.1)
Depreciation and amortization(95.7)(82.4)(273.4)(241.5)
Loss on disposal or impairment of assets(0.8)(1.9)(3.2)(2.4)
Loss on early extinguishment of debt— — (3.4)— 
Interest expense and amortization of debt discounts and fees(32.2)(30.8)(96.8)(93.0)
Net income attributable to noncontrolling interests53.7 48.1 160.9 135.9 
Change in fair market value of marketable securities(0.3)1.1 1.9 2.1 
Gain on sale of Gamma Knife— — 17.5 — 
State regulatory change impact on noncontrolling interests1.5 — 1.5 — 
Income from continuing operations before income tax expense$257.8 $219.9 $808.1 $695.3 
Schedule of Reconciliation of Revenue from Segments to Consolidated
Additional detail regarding the revenues of our operating segment by service line follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net operating revenues:
Inpatient$1,569.1 $1,427.3 $4,654.4 $4,258.7 
Other40.4 50.2 139.1 131.9 
Net operating revenues$1,609.5 $1,477.5 $4,793.5 $4,390.6